Onriva Trio Bexicap

Generic Name: Indacaterol, Glycopyrronium and Mometasone Furoate
Dosage Form: Dry Powder Inhaler, Capsule
TG Name: Respiratory

1. What is ONRIVA^® Trio Bexicap^®?
ONRIVA^® Trio Bexicap^® is the preparation of Indacaterol (150 µg), Glycopyrronium (50 µg), and Mometasone (160 µg) indicated as maintenance therapy in severe persistent asthma.

2. How ONRIVA^® Trio Bexicap^® works in our body?
ONRIVA^® Trio Bexicap^® works in 3 ways to control asthma symptoms. Indacaterol and Glycopyrronium help the muscles of lung airways to stay relaxed to prevent bronchoconstriction while Mometasone helps to decrease inflammation.

3. What are the indications of ONRIVA^® Trio Bexicap^®?
ONRIVA^® Trio Bexicap^® is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

4. What is the dosage & administration of ONRIVA^® Trio Bexicap^®?
The recommended dose of ONRIVA^® Trio Bexicap^® is 1 capsule once daily. ONRIVA^® Trio Bexicap^® should be taken using Bexihaler®.

5. What are the contraindications of ONRIVA^® Trio Bexicap^®?
ONRIVA^® Trio Bexicap^® is contraindicated in patients who have demonstrated hypersensitivity to indacaterol, glycopyrronium, mometasone furoate or any of the excipients used in this product.

6. What are the adverse effects of ONRIVA^® Trio Bexicap^®?
The most common adverse reactions were asthma exacerbation, nasopharyngitis, upper respiratory tract infections and headache. Other common adverse reactions included tachycardia, candidiasis, urinary tract infection, muscle spasms, cough, oropharyngeal pain, dysphonia, musculoskeletal pain, and pyrexia.

7. What would be the storage condition of ONRIVA^® Trio Bexicap^®?
Do not store above 30^°C. Do not refrigerate or freeze. Keep in a dry place. Protect from light & keep out of the reach of children.